Streetwise Reports

The Gold Report

The Energy Report

The Life Sciences Report

The Gold Report

The Energy Report

The Life Sciences Report

The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports

Innoviva Buys Remaining Shares in Advanced Antibiotic Co.

Streetwise Reports (05/23/2022)

Innoviva Buys Remaining Shares in Advanced Antibiotic Co.

Shares of Entasis Therapeutics traded 21% higher after the company reported it entered into a definitive merger agreement with Innoviva Inc., whereby Innoviva will acquire all outstanding shares of Entasis that it does not already own for $2.20 per share.

Tags: Biotechnology / Pharmaceuticals

H2/22 Slated to Be Catalyst Rich for Pharma Co.

Research Report

(05/21/2022)

H2/22 Slated to Be Catalyst Rich for Pharma Co.

Streetwise looks over the latest events surrounding Syros Pharmaceuticals after a Roth Capital Partners report shared that their newest updates could bolster the cash position of the firm and, thus, allow it to continue advancing all of its clinical programs.

Tags: Biotechnology / Pharmaceuticals

New Improved Drug Expected to Get FDA Approval Next Month

Research Report

(05/20/2022)

New Improved Drug Expected to Get FDA Approval Next Month

Greenlighting of its medication for urea cycle disorders is the first of a trio of catalysts anticipated for this U.S. pharma firm in 2022, noted a ROTH Capital Partners report. Streetwise reviews the newest updates in this drug development and the company's stock.

Tags: Biotechnology / Pharmaceuticals

US Pharma Co. Granted FDA Approval for IV Smallpox Drug

Streetwise Reports (05/20/2022)

US Pharma Co. Granted FDA Approval for IV Smallpox Drug

SIGA Technologies Inc. shares traded 30% higher after the company reported that the U.S. FDA has granted approval for an intravenous (IV) formulation of its TPOXX® (tecovirimat) for use in treating smallpox.

Tags: Biotechnology / Pharmaceuticals

Firm Reports Encouraging Trial Results in Cystinosis

Research Report

(05/19/2022)

Firm Reports Encouraging Trial Results in Cystinosis

New data from a Wedbush report shows that study patients experienced improvements in visual-motor integration, motor coordination, and visual perception. Streetwise Reports takes a deeper look at Avrobio Inc.

Tags: Biotechnology / Pharmaceuticals

EU Co. Secures Smallpox Vaccine Order to Target Monkeypox

Streetwise Reports (05/19/2022)

EU Co. Secures Smallpox Vaccine Order to Target Monkeypox

Shares of Danish vaccine company Bavarian Nordic A/S traded 70% higher after the company advised that it had secured a contract for its IMVANEX® smallpox vaccine from an undisclosed country in Europe for use in addressing newly confirmed cases of monkeypox.

Tags: Biotechnology / Pharmaceuticals

Coverage Launched on Co. in Alzheimer's Drug Space

Research Report

(05/17/2022)

Coverage Launched on Co. in Alzheimer's Drug Space

This biopharma's therapeutic candidates for central nervous system diseases stand out because of their selective and specific mechanism of action, noted a Leede Jones Gable report.

Tags: Biotechnology / Pharmaceuticals

Clinical Catalysts for Biotech's Stock On Track for Mid 2022

Research Report

(05/15/2022)

Clinical Catalysts for Biotech's Stock On Track for Mid 2022

Upcoming potential stock-moving events include new data concerning the company's lead therapeutic candidate for age-related eye diseases, noted a ROTH Capital Partners report.

Tags: Biotechnology / Pharmaceuticals

Biopharma Co. to Launch Two Clinical Trials This Year

Research Report

(05/14/2022)

Biopharma Co. to Launch Two Clinical Trials This Year

Success in either program, atopic dermatitis or asthma, "could lead to multiblockbuster sales," noted a ROTH Capital Partners report.

Tags: Biotechnology / Pharmaceuticals

Japan Pharma Co. Invests $275 Million in U.S. Oncology Firm

Streetwise Reports (05/13/2022)

Japan Pharma Co. Invests $275 Million in U.S. Oncology Firm

Cullinan Oncology Inc. shares traded 23% higher yesterday after the company reported it entered into a strategic investment, development and licensing agreement with Taiho Pharmaceutical Co. Ltd. of Japan for its CLN-081/TAS6417 for use in treatment of non-small cell lung cancer.

Tags: Biotechnology / Pharmaceuticals

First Results From Biotech Co.'s Lymphoma Program Are Impressive

Research Report

(05/13/2022)

First Results From Biotech Co.'s Lymphoma Program Are Impressive

This data will be presented at the 2022 annual meeting of the European Hematology Association on June 11th, noted a ROTH Capital Partners report.

Tags: Biotechnology / Pharmaceuticals

Pfizer Offers $11.6B to Buy Biopharma Co.

Streetwise Reports (05/10/2022)

Pfizer Offers $11.6B to Buy Biopharma Co.

Shares of Biohaven Pharmaceutical Holding Co. Ltd. traded almost 70% higher after the company reported it agreed to be acquired by Pfizer Inc. for $148.50 per share in cash plus future royalty opportunities.

Tags: Biotechnology / Pharmaceuticals

Biopharma Co. Licenses Orphan Drug to UK Firm for $450M

Streetwise Reports (05/05/2022)

Biopharma Co. Licenses Orphan Drug to UK Firm for $450M

Intercept Pharmaceuticals Inc. shares traded 20% higher after the company reported it entered into a $450 million licensing agreement with Advanz Pharma in markets outside of the U.S. for Ocaliva® for use in treatment of primary biliary cholangitis, a progressive and chronic autoimmune disease which affects the liver.

Tags: Biotechnology / Pharmaceuticals

Analyst Says Avivagen Is a Strong Buy

Contributed Opinion

Clive Maund (05/05/2022)

Analyst Says Avivagen Is a Strong Buy

With Avivagen's breakthrough product relishing in its success, Analyst Clive Maund reviews if he believes it is now a formidable contender as a Buy.

Tags: NutraceuticalsBiotechnology / Pharmaceuticals

Pilot Launch of VLN Cigarettes in Progress

Research Report

(05/03/2022)

Pilot Launch of VLN Cigarettes in Progress

These "very low nicotine" tobacco products will be an alternative for smokers when the FDA effects its imminent menthol cigarette ban, noted a ROTH Capital Partners report.

Tags: AgricultureBiotechnology / Pharmaceuticals

Biotech Co. Advances COVID-19 Vaccines Toward Approval

Research Report

(05/01/2022)

Biotech Co. Advances COVID-19 Vaccines Toward Approval

They include booster vaccines for different age groups of children and an Omicron-targeting booster for adults, noted an H.C. Wainwright & Co. report.

Tags: Biotechnology / Pharmaceuticals

Could a New Prescription Drug Treat This Common Ailment?

Research Report

(04/27/2022)

Could a New Prescription Drug Treat This Common Ailment?

The combination drug Halo-Lido is poised to be the first-of-its-kind prescription treatment approved by the U.S. Food and Drug Administration for this prevalent medical condition, noted a DawsonJames report.

Tags: Biotechnology / Pharmaceuticals

Biopharma Co. Posts 32% YoY Gain in Proprietary Sales

Streetwise Reports (04/27/2022)

Biopharma Co. Posts 32% YoY Gain in Proprietary Sales

Alkermes Plc. shares traded 12% higher after the Ireland-based company reported Q1/22 financial results and reiterated its FY/22 business outlook.

Tags: Biotechnology / Pharmaceuticals

Biopharma Co. Posts Positive Data in Ph. 1 Cancer Trials

Streetwise Reports (04/25/2022)

Biopharma Co. Posts Positive Data in Ph. 1 Cancer Trials

Nkarta Inc. shares traded over 120% higher after the company reported positive dosing data from two separate Phase 1 clinical trials evaluating the use of natural killer cell therapies to target r/r acute myeloid leukemia and myelodysplastic syndrome and r/r B cell malignancies.

Tags: Biotechnology / PharmaceuticalsRegenerative Medicine

FDA Grants RMAT Status for T-Cell Therapy for Six Viruses

Streetwise Reports (04/20/2022)

FDA Grants RMAT Status for T-Cell Therapy for Six Viruses

Shares of AlloVir Inc. traded 18% higher after the firm reported that the U.S. FDA awarded Regenerative Medicine Advanced Therapy designation to its posoleucel for use in preventing life-threatening infections from six viruses in allogeneic hematopoietic cell transplant patients.

Tags: Biotechnology / PharmaceuticalsRegenerative Medicine

Biotech Co.'s Shares Quadruple on $250M Buyout Bid

Streetwise Reports (04/19/2022)

Biotech Co.'s Shares Quadruple on $250M Buyout Bid

Shares of Checkmate Pharmaceuticals Inc. traded 330% higher to a new 52-week high after the company reported it agreed to be acquired by Regeneron Pharmaceuticals Inc. for $10.50 per share in cash.

Tags: Biotechnology / Pharmaceuticals

Senior Biotech Analyst's Top 3 Stocks

Streetwise Reports (04/19/2022)

Senior Biotech Analyst's Top 3 Stocks

Streetwise Reports recently spoke to renowned biotech expert John Vandermosten (CFA) about three of his favorite healthcare companies that are addressing as-of-yet unmet market needs.

Tags: Biotechnology / Pharmaceuticals

Life Sciences Co. Expected to Attract Partners, Big Pharma

Research Report

(04/19/2022)

Life Sciences Co. Expected to Attract Partners, Big Pharma

"We foresee continued execution on its developmental strategy," noted Argus Research on this development stage biotech company tackling neurodegenerative diseases.

Tags: Biotechnology / Pharmaceuticals

Vaccine Maker Awarded Approval for COVID-19 Vaccine

Streetwise Reports (04/14/2022)

Vaccine Maker Awarded Approval for COVID-19 Vaccine

Shares of Valneva SE traded 8.5% higher after the company reported that the U.K.'s MHRA has granted Conditional Marketing Authorization for its inactivated whole-virus COVID-19 vaccine candidate called VLA2001 for primary immunization in adults between 18 and 50 years old.

Tags: Biotechnology / Pharmaceuticals

GSK Offers $1.9B for Cancer-Focused Pharma Co.

Streetwise Reports (04/13/2022)

GSK Offers $1.9B for Cancer-Focused Pharma Co.

Shares of Sierra Oncology Inc. traded 38% higher after the company reported it agreed to be acquired by GlaxoSmithKline Plc. for $55 per share in cash.

Tags: Biotechnology / Pharmaceuticals

Showing Results: 1 to 25 of 109 Next

More Experts

"We have a Buy recommendation on OMM."

❭

– Chris Temple, The National Investor

"We have a Buy recommendation on QPM."

❭

– Chris Temple, The National Investor

"MMG is starting to look like a Buy here."

❭

– Clive Maund, CliveMaund.com

"MAG reported Q1/22 production generally in line with our estimates."

❭

– Chris Thompson, PI Financial

"POE is planning to liquidate the Thai assets and pay out shareholders."

❭

– Chen Lin, What Is Chen Buying? What Is Chen Selling?